Peer Review History
| Original SubmissionJuly 19, 2024 |
|---|
|
Dear Dr. Zhang, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jan 02 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Ricardo Jorge Alcobia Granja Rodrigues, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for uploading your study's underlying data set. Unfortunately, the repository you have noted in your Data Availability statement does not qualify as an acceptable data repository according to PLOS's standards. At this time, please upload the minimal data set necessary to replicate your study's findings to a stable, public repository (such as figshare or Dryad) and provide us with the relevant URLs, DOIs, or accession numbers that may be used to access these data. For a list of recommended repositories and additional information on PLOS standards for data deposition, please see https://journals.plos.org/plosone/s/recommended-repositories . 3. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process. 4. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. 5. Please remove your figures from within your manuscript file, leaving only the individual TIFF/EPS image files, uploaded separately. These will be automatically included in the reviewers’ PDF Additional Editor Comments (if provided): Your manuscript has a number of strengths, but before being considered for publication I would recommend that you clearly engage with the suggestions made by reviewer 1. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: This study used CHARLS data to investigate the impacts of long-term care insurance on household expenditure in China. I have the following comments: Introduction and literature 1. 'As physical functions decline with age, the probability of elderly individuals suffering from chronic diseases rise to 56%'. It is unclear what this sentence means exactly. 2. The concepts of medical care and long-term care should be clearly defined. It is mentioned that 'the aim (of long term care insurance) is to provide comprehensive medical care servies and financial support for the disabled elderly. What are the relationships between long term care and medical care? 3.References should be added to support some of the discussion points. For example, (1) Barthel Scale (2) The description of the healthcare insurance and long-term care insurance in China; (3) previous studies focusing on the impacts of LTCI Method: 1. Clarify the relationships between health care expenditure, medical expenditure, and non-medical expenditure. Are they mutually exclusive? 2. Table 2: Why the mean value of the LTCI particpation variable for the treated group is 0.5 not 1? And why its standard deviation is also 0.5? 3. Report the level of missingness for the expenditure variables and how missingness has been handled. 4. Equations (2)-(4). The interaction term between Treat and Time is included in the models but the main effects (i.e., Treat and Time separately) are excluded from the models. It is unknown what the interaction term is trying to estimate in this case. 5. In equation (4), Y in time point t+1 is treated as the outcome variable, but Y in time point t is not controlled for. This leads to endogeneity bias. Results: 1. The discussion relating to LTCI as a health protection tool (above Table 7) should be moved to the discussion section, as these are interpretation of the results. 2. The statistical significance of the mediation effect should be formally tested. Relying on the significance of the two coefficients (i.e., DID on mediator and mediator on final outcome) is not always reliable. Discussion: 1. 'LTCI reduces the need for preventative savings, which leads to improved wellbeing and quality of life'. These are interpretation of the results and implications of the research findings. Author discussed them in a way as if they are research findings directly supported by data, which can be confusing. These points should be re-written. 2. Authors recommended a care model that combines community and family care and reduce institutional care. Information technology should be integrated. It is difficult to see how these are relevant to the research findings of LTCI in this study. Reviewer #2: 1. Technical Soundness and Data Support: The study applies a DID approach using longitudinal data from CHARLS, providing empirical support for assessing the impact of LTCI on elderly household expenditures. The data spans three periods (2015-2020), offering sufficient variation for analysis. The conclusions align well with the data findings, which reveal significant effects of LTCI on various types of expenditures for the elderly, supporting the authors' assertions about LTCI's impact on expenditure patterns. 2. Statistical Analysis: Statistical rigor is achieved through a combination of PSM and DID, addressing potential selection biases and establishing robust comparative groups. Additionally, the manuscript conducts robustness checks via individual placebo tests, price index adjustments, and dependent variable substitutions. These elements collectively validate the impact of LTCI, indicating that the statistical analysis was appropriately conducted. 3. Data Availability: The authors have made the CHARLS dataset accessible through a public repository, with details in the manuscript, meeting the criteria for data transparency. This ensures that the findings are reproducible by others with access to the CHARLS data. 4. Presentation and Language: The manuscript is presented in a clear, intelligible manner, with a structured flow from hypothesis development to methodological details, results, and conclusions. Key terms are defined early, and tables summarize statistical results effectively. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
The Impact of Long-Term Care Insurance on Household Expenditures of the Elderly: Evidence from China PONE-D-24-29983R1 Dear Dr. Zhang, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Ricardo Jorge Alcobia Granja Rodrigues, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes ********** Reviewer #1: Authors have addressed all of my comments well. In particular, I am glad that authors have used the bootstrap method to formally assess the statistical significance of the mediation effects. I am aware that the Baron-Kenny's three-step approach has a long history and has been widely used in previous studies. But there has also been an increasing number of studies pointing out its flaws in reasoning: having two statistically significant coefficients does not guarantee that the product of the two coefficients is statistically significant as well (sometimes it does while other times it does not). It has always been my view that formally testing the mediation effects will definitely help to further enhance the rigour of a study. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No ********** |
| Formally Accepted |
|
PONE-D-24-29983R1 PLOS ONE Dear Dr. Zhang, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Ricardo Jorge Alcobia Granja Rodrigues Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .